基于功能性胃肠病的量表疗效评价研究进展

功能性胃肠病(functional gastrointestinal disorder,FGIDs)又称肠-脑互动异常1]。成人类的FGIDs包含6类,其在症状上常相互重叠,并且有其共通的病理机制。目前认为FGIDs的"生物-心理-社会模式"是其病理生理决定因素1]。因此,在FGIDs的临床试验中,主要目标是改善患者所诉的症状和体征。

Research progress of efficacy evaluation of scale based on functional gastrointestinal disorder

As a kind of scale that can directly reflect the symptoms and problems that patients are most concerned about, it is a supplement to the outcome index of clinical efficacy evaluation. Based on the current development of functional gastrointestinal disorder scale at home and abroad, a comprehensive review of the current application in indigestion, reflux hypersensitivity, irritable bowel syndrome, constipation and so on scale, summarizes the basic situation of various scale and its application scope, summarizes current problems of scale, and analyzes the difficulties faced by the diseases of the functional gastrointestinal disorder scale in China and the existing gap, scale development trend was forecasted.